Strategies to minimize risks and exploitation in phase one trials on healthy subjects.
Most of the literature on phase one trials has focused on ethical and safety issues in research on patients with advanced cancer, but this article focuses on healthy, adult subjects. The article makes six specific recommendations for protecting the rights and welfare of healthy subjects in phase one trials: 1) because phase one trials are short in duration (usually 1 to 3 months), researchers should gather more data on the short-term and long-term risks of participation in phase one studies by healthy subjects; 2) researchers should develop strict inclusion/exclusion criteria that exclude unhealthy or vulnerable subjects, such as decisionally impaired people, in phase one studies; 3) subjects should not participate in more than one phase one study at the same time and should wait at least 30 days between participating in different studies; 4) researchers should develop a database to keep track of phase one participants; 5) subjects should be guaranteed a minimum wage equivalent to the equivalent type of unskilled labor, but there should be no upper limits on wages; and 6) subjects should be allowed to engage in collective bargaining with research sponsors.
Shamoo
Adil E
AE
School of Medicine, University of Maryland, USA.
Resnik
David B
DB
D000328:Adult; D002755:Choice Behavior; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics* / Q000592:standards*; D003068:Coercion; D028744:Ethics Committees, Research; D017408:Guidelines as Topic; D006801:Humans; D007258:Informed Consent; D018579:Patient Selection / Q000941:ethics; D012108:Research Personnel; D035842:Research Subjects / Q000191:economics / Q000523:psychology; D018570:Risk Assessment; D012449:Safety; D012456:Salaries and Fringe Benefits; D012923:Social Class; D035862:Vulnerable Populations